Yaxincheng
Specialized life sciences and medical translation services
About Yaxincheng
Beijing Yaxincheng Medical InfoTech Co., Ltd. is a language service provider specializing in medical translation. Founded in 2000 by Ruifeng Yang, the company, formerly known as Beijing Yaxincheng Translation Center, initially established itself in Beijing. A strategic shift in 2003 focused the company exclusively on the medical and life sciences sector. This specialization proved successful, and by 2011, Yaxincheng had become a prominent player in the domestic medical translation industry and obtained ISO 9001 certification.
Yaxincheng provides translation services for a wide range of materials across the entire lifecycle of medical products, from pre-clinical research to post-market surveillance. This includes documents for drugs, medical devices, in-vitro diagnostics (IVDs), biologics, veterinary drugs, and cosmetics. The company handles various document types such as clinical research, regulatory registration dossiers, marketing materials, and training documents in multiple languages including Chinese, English, Japanese, German, and French. Its client base consists of pharmaceutical companies, medical device manufacturers, biotechnology firms, and contract research organizations (CROs).
In July 2019, the company was acquired by Hangzhou Tigermed Consulting Company, and by December 2020, it became a wholly-owned subsidiary of Tigermed, a major Chinese CRO. This acquisition marked a significant milestone, integrating Yaxincheng into a larger healthcare services ecosystem. The firm has been recognized as a National High-tech Enterprise since 2017.
Source: Dealroom company dataNews
Open roles
Yaxincheng in the Dongcheng District ecosystem
The Yaxincheng office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Hangzhou Tigermed
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Yaxincheng on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yaxincheng on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.